Zonisamide

Phase 3Completed

1 views this week 0 watching⚡ Active

Interest: 40/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

Phase 3

Approved

Indication / Disease

Epilepsy, Complex Partial

Conditions

Epilepsy, Complex Partial

Trial Timeline

Feb 1, 2002 → Oct 1, 2004

NCT ID

NCT00056576

About Zonisamide

Zonisamide is a phase 3 stage product being developed by Eisai for Epilepsy, Complex Partial. The current trial status is completed. This product is registered under clinical trial identifier NCT00056576. Target conditions include Epilepsy, Complex Partial.

What happened to similar drugs?

20 of 20 similar drugs in Epilepsy, Complex Partial were approved

Approved (20) Terminated (6) Active (0)

✅ZonegranEisaiApproved

✅Perampanel + PlaceboEisaiApproved

✅perampanelEisaiApproved

✅Perampanel Oral TabletEisaiApproved

✅PerampanelEisaiApproved

✅zonisamide low dose group + zonisamide high dose groupEisaiApproved

✅Zonisamide at targeted daily doses of 100-500 mg/day + Placebo administered to match targeted daily doses of 100-500 mg/dayEisaiApproved

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (6)

NCT ID	Phase	Status	Start	Completion	Indication
NCT01283256	Pre-clinical	Completed	Jan 1, 2011	May 1, 2013	Partial, Generalized and Combined Seizures
NCT01136954	Phase 3	Completed	Jul 1, 2008	Mar 1, 2012	Partial Seizures
NCT00659958	Approved	Completed	Apr 1, 2008	Sep 1, 2009	Epilepsy
NCT01140867	Approved	Completed	Feb 29, 2008	Mar 31, 2011	Epilepsy
NCT00259636	Approved	Withdrawn	Aug 1, 2004	Jan 1, 2008	Fibromyalgia
NCT00056576	Phase 3	Completed	Feb 1, 2002	Oct 1, 2004	Epilepsy, Complex Partial

Competing Products

20 competing products in Epilepsy, Complex Partial

See all competitors

Product	Company	Stage	Hype Score
perampanel	Eisai	Phase 2	35
Lacosamide	UCB	Phase 3	40
Zonisamide + Placebo	Eisai	Phase 3	32
Zonegran	Eisai	Approved	35
perampanel + perampanel	Eisai	Phase 1	29
Perampanel + Placebo	Eisai	Approved	35
perampanel	Eisai	Approved	35
E2007 + Placebo	Eisai	Phase 2	35
Placebo + Rufinamide	Eisai	Phase 3	40
E2007 (perampanel) + Placebo	Eisai	Phase 2	35
Perampanel Oral Tablet	Eisai	Approved	43
perampanel	Eisai	Phase 3	40
Perampanel	Eisai	Pre-clinical	26
Zonisamide + Carbamazepine	Eisai	Phase 3	40
Perampanel	Eisai	Approved	43
Perampanel and Microgynon-30 + Perampanel and Microgynon-30	Eisai	Phase 1	29
Perampanel	Eisai	Phase 2	35
Zonisamide + Placebo	Eisai	Phase 3	40
zonisamide low dose group + zonisamide high dose group	Eisai	Approved	43
E2007 + E2007 + Placebo	Eisai	Phase 2	35